Bionano Genomics (BNGO) Non Operating Interest Expenses (2017 - 2024)

Bionano Genomics has disclosed Non Operating Interest Expenses across 8 years of filings, most recently posting $122000.0 for Q1 2024.

• In Q1 2024, Non Operating Interest Expenses rose 60.53% year-over-year to $122000.0; the TTM figure through Mar 2024 stood at $5.2 million (up 1633.22% YoY), while the FY2023 annual figure was $5.1 million, up 1617.79% from the prior year.
• Non Operating Interest Expenses came in at $122000.0 for Q1 2024 at Bionano Genomics, down from $4.9 million in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $4.9 million in Q4 2023 to a low of $2000.0 in Q3 2021.
• Average Non Operating Interest Expenses over 5 years is $528882.4, with a median of $77000.0 recorded in 2022.
• Year-over-year, Non Operating Interest Expenses slumped 99.66% in 2021 and soared 6430.67% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $608000.0 in 2020, then tumbled by 95.56% to $27000.0 in 2021, then surged by 177.78% to $75000.0 in 2022, then soared by 6430.67% to $4.9 million in 2023, then plunged by 97.51% to $122000.0 in 2024.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $122000.0 in Q1 2024, $4.9 million in Q4 2023, and $71000.0 in Q3 2023.